Exelixis (EXEL) free cash flow

Free cash flow · fiscal 2025
$844.34M

Exelixis (EXEL) generated free cash flow of $844.34M in fiscal 2025 (the year ended December 31, 2025). That is 33.2% higher than the $633.79M of fiscal 2024. Figures as of 18 Nov 2026, 12:00 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$844.34M
Change on fiscal 2024
+33.2%
Growth, 5 years
+10.4% a year
Highest on record
$844.34Mfiscal 2025
Lowest on record
-$235.88Mfiscal 2014
Fiscal years on record
192009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Exelixis free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 10.4% a year. Across the 19 fiscal years on record (2009–2025), the highest was $844.34M in fiscal 2025 and the lowest -$235.88M in fiscal 2014.

History · 19 fiscal years

Free cash flow by fiscal year

Exelixis free cash flow, year by year

Exelixis (EXEL) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$844.34M 33.2% up
2024$633.79M 272.0% up
2023$170.36M 24.0% down
2022$224.16M 35.3% down
2021$346.58M—
2021$178.64M 65.3% down
2020$514.12M—
2018$382.42M 164.7% up
2017$144.47M 29.4% down
2016$204.59M—
2016$208.70M—
2016-$141.50M—
2015-$142.03M—
2014-$235.88M—
2013-$200.94M—
2012-$125.86M—
2011-$160.22M—
2010-$102.86M—
2009-$20.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Exelixis and comparable companies
CompanyFree cash flowFiscal year
Medpace Holdings MEDP$681.87M2025
Revvity RVTY$509.41M2025
Exelixis EXEL$844.34M2025
Charles River Laboratories International CRL$518.49M2025
Neurocrine Biosciences NBIX$748.70M2025
Ascendis Pharma ASND€45.41M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EXEL

Exelixis, figure by figure

Exelixis (EXEL) overview: price, valuation and scorecardAll health care companies by market value

Exelixis free cash flow: questions and answers

What is Exelixis's free cash flow?

Exelixis (EXEL) generated free cash flow of $844.34M in fiscal 2025 (the year ended December 31, 2025). That is 33.2% higher than the $633.79M of fiscal 2024.

What is the growth rate of Exelixis's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 10.4% a year.

What are the highest and lowest free cash flow figures on record for Exelixis?

Across the 19 fiscal years on record (2009–2025), the highest was $844.34M in fiscal 2025 and the lowest -$235.88M in fiscal 2014.

How is Exelixis's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Exelixis it is on record here for 19 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Exelixis (EXEL) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/EXEL/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.